Ubicación del inventario

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Sujeto a disponibilidad

Documentation

Descargar MSDS

Descargar COA de muestra

Incluye: HPLC, MASS/LC-MS, RMN de 1H, FT-IR, potencia, informe de elucidación estructural (SER) y datos analíticos adicionales según el producto.

455-14-1Leflunomide EP Impurity A

● En Stock

Número de catálogo:	VL1060002
N.º CAS:	455-14-1
Fórmula mol.::	C7H6F3N
Peso mol.::	161.12 g/mol

Solicitar cotización

Añadir a la lista de RFQ

Información adicional sobre el CAS 455-14-1

Fármaco de origen

Leflunomide

Nombre IUPAC

4-(trifluoromethyl) aniline

Sinónimos farmacopeicos

Leflunomide Related Compound A

Otros sinónimos

4-(Trifluoromethyl)benzenamine;p-Aminobenzotrifluoride;[4-(trifluoromethyl)phenyl]amine

SMILES

NC1=CC=C(C(F)(F)F)C=C1

InChI

InChI=1S/C7H6F3N/c8-7(9,10)5-1-3-6(11)4-2-5/h1-4H,11H2

Descripción

Leflunomide EP Impurity A also known as Leflunomide Related Compound A, in various pharmacopoeias, is a highly characterized standard. It meets strict regulatory requirements set by USP, EMA, JP, and BP, making it a crucial component in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Leflunomide.

Referencias

Saini, Balraj, and Gulshan Bansal. “Isolation and Characterization of a Degradation Product in Leflunomide and a Validated Selective Stability-Indicating HPLC–UV Method for Their Quantification.” Journal of Pharmaceutical Analysis, vol. 5, no. 3, June 2015, pp. 207–12, https://doi.org/10.1016/j.jpha.2014.10.003. ?